Process View
Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of wound healing"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| VEGFA | vascular endothelial growth factor A | 0.999 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.999 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.993 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.992 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.988 | Human | |
| NRP1 | neuropilin 1 | 0.986 | ||
| PLAU | plasminogen activator, urokinase | 0.919 | Human Mouse | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.878 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.835 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.827 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.770 | ||
| FGA | fibrinogen alpha chain | 0.765 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.726 | Human | |
| PLG | plasminogen | 0.718 | ||
| KNG1 | kininogen 1 | 0.663 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.626 | ||
| A2M | alpha-2-macroglobulin | 0.622 | Human | |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.619 | ||
| ACTB | actin, beta | 0.553 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.543 | ||
| FGB | fibrinogen beta chain | 0.517 | ||
| PDGFC | platelet derived growth factor C | 0.458 | ||
| APOE | apolipoprotein E | 0.435 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.419 | ||
| SYK | spleen tyrosine kinase | 0.404 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.394 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.379 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.368 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.361 | Human | |
| S100A10 | S100 calcium binding protein A10 | 0.350 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.341 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.330 | ||
| PLAT | plasminogen activator, tissue | 0.322 | Human | |
| HP | haptoglobin | 0.322 | ||
| INADL | InaD-like (Drosophila) | 0.322 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.283 | ||
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.237 | ||
| FGF10 | fibroblast growth factor 10 | 0.205 | Human | |
| APOC1 | apolipoprotein C-I | 0.196 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.174 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.160 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.144 | ||
| C1S | complement component 1, s subcomponent | 0.139 | ||
| FGF7 | fibroblast growth factor 7 | 0.139 | Human | |
| APOC3 | apolipoprotein C-III | 0.134 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.132 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.125 | ||
| APOA2 | apolipoprotein A-II | 0.124 | ||
| SMAD2 | SMAD family member 2 | 0.121 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.118 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.118 | Human | |
| VWF | von Willebrand factor | 0.116 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.113 | ||
| F11 | coagulation factor XI | 0.113 | ||
| EMP1 | epithelial membrane protein 1 | 0.096 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.093 | Human | |
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.091 | ||
| ALB | albumin | 0.088 | ||
| GYPC | glycophorin C (Gerbich blood group) | 0.080 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.070 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.070 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.069 | ||
| DCN | decorin | 0.069 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.068 | ||
| ANXA1 | annexin A1 | 0.067 | ||
| CDCP1 | CUB domain containing protein 1 | 0.067 | ||
| LIN7A | lin-7 homolog A (C. elegans) | 0.066 | ||
| C6 | complement component 6 | 0.064 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.063 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.061 | ||
| HRG | histidine-rich glycoprotein | 0.056 | Mouse | |
| ENG | endoglin | 0.054 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.052 | ||
| VEGFC | vascular endothelial growth factor C | 0.050 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.050 | ||
| CYP2A7 | cytochrome P450, family 2, subfamily A, polypeptide 7 | 0.046 | ||
| F11R | F11 receptor | 0.046 | ||
| PGF | placental growth factor | 0.045 | Human | |
| STAB1 | stabilin 1 | 0.045 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.045 | ||
| VTN | vitronectin | 0.044 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.043 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.043 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.043 | ||
| C8A | complement component 8, alpha polypeptide | 0.043 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.043 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.042 | Human | |
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.042 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.041 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.041 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.041 | ||
| ORM1 | orosomucoid 1 | 0.040 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.040 | Human | |
| WNT2 | wingless-type MMTV integration site family member 2 | 0.039 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.039 | ||
| SDC2 | syndecan 2 | 0.039 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.037 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.037 | ||
| FN1 | fibronectin 1 | 0.036 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.036 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.036 | ||
| C8B | complement component 8, beta polypeptide | 0.036 | ||
| LDLR | low density lipoprotein receptor | 0.036 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.035 | ||
| LPA | lipoprotein, Lp(a) | 0.034 | Human | |
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.034 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.034 | ||
| AFM | afamin | 0.034 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.033 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.031 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.030 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.030 | ||
| ACTG1 | actin, gamma 1 | 0.030 | ||
| HAP1 | huntingtin-associated protein 1 | 0.029 | ||
| TTR | transthyretin | 0.028 | ||
| AXL | AXL receptor tyrosine kinase | 0.028 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.028 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.028 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.028 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.028 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.027 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.026 | ||
| PTH1R | parathyroid hormone 1 receptor | 0.025 | ||
| ITGB5 | integrin, beta 5 | 0.024 | ||
| THBS2 | thrombospondin 2 | 0.024 | Human | |
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.024 | ||
| C2 | complement component 2 | 0.024 | ||
| OSMR | oncostatin M receptor | 0.023 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.023 | ||
| F10 | coagulation factor X | 0.023 | Human | |
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.023 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.023 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.023 | ||
| FGG | fibrinogen gamma chain | 0.023 | ||
| ANGPT2 | angiopoietin 2 | 0.022 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.022 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.021 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.021 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.021 | Human Mouse | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.021 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.021 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.020 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.020 | ||
| HPN | hepsin | 0.020 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.020 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.020 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.019 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.019 | ||
| STC1 | stanniocalcin 1 | 0.019 | ||
| MAPT | microtubule-associated protein tau | 0.018 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.018 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.018 | ||
| F2 | coagulation factor II (thrombin) | 0.018 | ||
| LIPC | lipase, hepatic | 0.018 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.017 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.017 | Human | |
| CD248 | CD248 molecule, endosialin | 0.017 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.017 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.017 | ||
| DPYS | dihydropyrimidinase | 0.017 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.017 | ||
| PON3 | paraoxonase 3 | 0.016 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.016 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.016 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.016 | ||
| MSN | moesin | 0.016 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.016 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.016 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.016 | ||
| HABP2 | hyaluronan binding protein 2 | 0.016 | Human | |
| FGFR3 | fibroblast growth factor receptor 3 | 0.016 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.016 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.015 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.015 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.015 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.015 | ||
| BLNK | B-cell linker | 0.015 | ||
| PLTP | phospholipid transfer protein | 0.015 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.015 | Human | |
| F9 | coagulation factor IX | 0.015 | Human | |
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.015 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.015 | ||
| STAB2 | stabilin 2 | 0.015 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.015 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.015 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.015 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.014 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.014 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.014 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.014 | Human | |
| S100A11 | S100 calcium binding protein A11 | 0.014 | ||
| ECM1 | extracellular matrix protein 1 | 0.014 | ||
| EMP3 | epithelial membrane protein 3 | 0.014 | ||
| EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | 0.014 | ||
| PLXDC1 | plexin domain containing 1 | 0.013 | ||
| APCS | amyloid P component, serum | 0.013 | ||
| MRVI1 | murine retrovirus integration site 1 homolog | 0.013 | ||
| MRC1 | mannose receptor, C type 1 | 0.013 | ||
| FMOD | fibromodulin | 0.013 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.013 | ||
| MMP19 | matrix metallopeptidase 19 | 0.013 | ||
| CPN2 | carboxypeptidase N, polypeptide 2 | 0.013 | ||
| HAS2 | hyaluronan synthase 2 | 0.013 | ||
| CFHR2 | complement factor H-related 2 | 0.013 | ||
| APOC4 | apolipoprotein C-IV | 0.013 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.013 | ||
| TAT | tyrosine aminotransferase | 0.013 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.013 | ||
| RPH3A | rabphilin 3A homolog (mouse) | 0.013 | ||
| MYO1D | myosin ID | 0.013 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.012 | ||
| PRKCB | protein kinase C, beta | 0.012 | ||
| FETUB | fetuin B | 0.012 | ||
| BMP4 | bone morphogenetic protein 4 | 0.012 | ||
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.012 | ||
| C4B | complement component 4B (Chido blood group) | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.012 | ||
| EZR | ezrin | 0.012 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.012 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.012 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.011 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.011 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.011 | ||
| FGL1 | fibrinogen-like 1 | 0.011 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.011 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.011 | Rat | |
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.011 | ||
| APOC2 | apolipoprotein C-II | 0.011 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.011 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.011 | ||
| COMP | cartilage oligomeric matrix protein | 0.011 | Human | |
| A1BG | alpha-1-B glycoprotein | 0.011 | ||
| FCN3 | ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| CNTNAP2 | contactin associated protein-like 2 | 0.011 | ||
| EGFR | epidermal growth factor receptor | 0.011 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.011 | ||
| CCL16 | chemokine (C-C motif) ligand 16 | 0.011 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.011 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.011 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.011 | ||
| TMSB10 | thymosin beta 10 | 0.011 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.011 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.011 | Human | |
| AVPR2 | arginine vasopressin receptor 2 | 0.011 | ||
| HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 | 0.011 | ||
| CHRD | chordin | 0.011 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.011 | Human | |
| SEMA5B | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B | 0.011 | ||
| DAO | D-amino-acid oxidase | 0.011 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.010 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.010 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.010 | ||
| SLC17A3 | solute carrier family 17 (sodium phosphate), member 3 | 0.010 | ||
| APOA1 | apolipoprotein A-I | 0.010 | Human | |
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.010 | ||
| TM4SF4 | transmembrane 4 L six family member 4 | 0.010 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.010 | ||
| SDS | serine dehydratase | 0.010 | ||
| HGFAC | HGF activator | 0.010 | Human | |
| AEBP1 | AE binding protein 1 | 0.010 | ||
| MARCO | macrophage receptor with collagenous structure | 0.010 | ||
| INHBA | inhibin, beta A | 0.010 | ||
| GDF9 | growth differentiation factor 9 | 0.010 | ||
| SARDH | sarcosine dehydrogenase | 0.010 | ||
| TRIM9 | tripartite motif containing 9 | 0.010 | ||
| ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.010 | Human | |
| KRT5 | keratin 5 | 0.010 | ||
| NID1 | nidogen 1 | 0.010 |